FINHUB Insights

STE · Q4 FY26 · Jan 1 – Mar 31, 2026

Steris Q4 FY26: where the revenue came from and where it went

Steris Q4 FY26: revenue $1.6B (+7% year over year). Net profit $0.2B. Largest cohort Healthcare Segment $1.1B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jan 1 – Mar 31, 2026
Reported
May 29, 2026 10-K
Sankey diagram of Steris's income statement for Q4 FY26: revenue of $1.6 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$1.6B +7% year over year
Gross profit$0.7B 44% margin
Operating profit$0.3B 20% margin
Net profit$0.2B 14% margin

The numbers

All figures in billions of U.S. dollars, for Q4 FY26 (period ends Mar 31, 2026).
ItemValueShare of revenueYear over year
Revenue 1.6 100% +7%
Healthcare Segment 1.1 69% +7%
Applied Sterilization Technologies 0.3 19% +6%
Life Science Member 0.2 12% +9%
Cost of revenue−0.956%
Gross profit0.744% margin+1pp
Research & development−02%+0pp
SG&A−0.422%+0pp
Operating profit0.320% margin+5pp
Tax−0.1
Net profit0.214%+4pp
Filing on EDGAR More quarters of STE

Source of the numbers: structured XBRL data from the filing (10-K). The diagram is generated automatically and checked against EDGAR before release. The fourth quarter has no column of its own in an annual report, so it is the full year minus the first nine months. How we calculate it → About and methodology.

Older quarters